Ryan T. Cirz
Codagenix (United States)(US)
Publications by Year
Research Areas
Antibiotic Resistance in Bacteria, Bacterial Genetics and Biotechnology, Antibiotics Pharmacokinetics and Efficacy, Cancer therapeutics and mechanisms, DNA Repair Mechanisms
Most-Cited Works
- → Inhibition of Mutation and Combating the Evolution of Antibiotic Resistance(2005)577 cited
- → Defining the Pseudomonas aeruginosa SOS Response and Its Role in the Global Response to the Antibiotic Ciprofloxacin(2006)268 cited
- → Complete and SOS-Mediated Response of Staphylococcus aureus to the Antibiotic Ciprofloxacin(2006)267 cited
- → Structural and Initial Biological Analysis of Synthetic Arylomycin A2(2007)114 cited
- → Induction and Inhibition of Ciprofloxacin Resistance-Conferring Mutations in Hypermutator Bacteria(2005)104 cited
- → Leaks in the Pipeline: a Failure Analysis of Gram-Negative Antibiotic Development from 2010 to 2020(2022)99 cited
- → Interaction of Drug- and Granulocyte-Mediated Killing of Pseudomonas aeruginosa in a Murine Pneumonia Model(2014)77 cited
- → Optimization of LpxC Inhibitors for Antibacterial Activity and Cardiovascular Safety(2019)75 cited
- → Controlling Mutation: Intervening in Evolution as a Therapeutic Strategy(2007)72 cited
- → Potent LpxC Inhibitors with In Vitro Activity against Multidrug-Resistant Pseudomonas aeruginosa(2019)59 cited